Join ASGCT and save up to $350 on Annual Meeting registration!
Learn more about sessions and presentations at the 26th Annual Meeting
Friday, May 19 2023 08:00 AM – 09:45 AM PT
The in vivo delivery of therapeutic agents is a promising avenue for the treatment of many diseases, disorders, and malignancies. However, in vivo new challenges arise to reach the cells of interest reliably and safely. This session focuses on the broad variety of targeted carriers for in vivo delivery to enable specificity and avoid clearance as well as off-target effects.
08:00 AM – 09:45 AM - Room 408 AB
Stefan Radtke, PhD. Fred Hutchinson Cancer Center, Seattle, WA
Anastasia Khvorova, PhD. University of Massachusetts Medical School, Worcester, MA
08:01 AM – 08:25 AM - Room 408 AB
Hamideh Parhiz. University of Pennsylvania, Philadelphia, PA
08:25 AM – 08:50 AM - Room 408 AB
Jilliane Perkins. , WA
08:50 AM – 09:15 AM - Room 408 AB
Semih U.. Tareen. Sana Biotechnology, Seattle, WA
© 2000-2023 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico